Trial intelligence / Profile preview

TAILoR trial of telmisartan for insulin resistance in adults with HIV on cART

ISRCTN51069819Phase 2Completed

Sponsor
University of Liverpool
Start
Mar 2013
Modality
Small Molecules
01

Overview

Phase 2, randomised, open-label trial of telmisartan in insulin resistance (IR) and human immunodeficiency virus infection (HIV), sponsored by University of Liverpool. Started Mar 2013; status: completed.

02

Drugs

telmisartan
03

Conditions

insulin resistance (IR)human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on ISRCTN51069819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN51069819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call